Lawrence A. Kenyon

2020

In 2020, Lawrence A. Kenyon earned a total compensation of $1.2M as Director, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Corporate Secretary at Outlook Therapeutics, a 36% decrease compared to previous year.

Compensation breakdown

Bonus$116,875
Option Awards$621,449
Salary$425,000
Other$21,010
Total$1,184,334

Kenyon received $621.4K in option awards, accounting for 52% of the total pay in 2020.

Kenyon also received $116.9K in bonus, $425K in salary and $21K in other compensation.

Rankings

In 2020, Lawrence A. Kenyon's compensation ranked 7,890th out of 13,090 executives tracked by ExecPay. In other words, Kenyon earned more than 39.7% of executives.

ClassificationRankingPercentile
All
7,890
out of 13,090
40th
Division
Manufacturing
3,345
out of 5,617
40th
Major group
Chemicals And Allied Products
1,354
out of 2,248
40th
Industry group
Drugs
1,176
out of 1,948
40th
Industry
Biological Products, Except Diagnostic Substances
277
out of 411
33rd
Source: SEC filing on February 22, 2021.

Kenyon's colleagues

We found two more compensation records of executives who worked with Lawrence A. Kenyon at Outlook Therapeutics in 2020.

2020

Terry Dagnon

Outlook Therapeutics

Chief Operating Officer

2020

Jeff Evanson

Outlook Therapeutics

Chief Commercial Officer

News

In-depth

You may also like